Q4 2028
Ends Oct 31, 2028
Revenue
$2.2B
$2.2B to $2.2B
EPS
2.02
2.00 to 2.03
No analyst count
EPS: No analyst count
May 5, 11:53 AM UTC
stable/analyst-estimates
Healthcare
Quote through 2026-08-05T13:30:00Z · Stale
Quote synced 2026-08-05T23:22:02.180666Z
Daily bars through 2026-08-04 · Delayed
Daily bars synced 2026-08-05T04:43:34.989679Z
Fundamentals through 2025-10-31 · Stale
Fundamentals synced 2026-08-05T22:39:51.787625Z
Forecasts: Stale
Forecasts synced 2026-05-05T11:53:49.765898Z
Ownership through 2025-10-31 · Stale
Ownership synced 2026-08-05T22:39:51.787625Z
Short interest through 2025-10-31 · Stale
Short interest synced 2026-08-05T22:39:51.787625Z
News through 2026-07-31T13:20:00Z · Stale
News synced 2026-08-02T07:26:53.664136Z
Company profile: Delayed
Company profile synced 2026-05-06T21:55:58.178672Z
Regular-session price
Offline$141.11
+1.37% regular session
1Y Change
+21.16%
Window
Aug 5, 2025 → Aug 4, 2026
Investment Snapshot
Valuation, growth, profitability, catalysts, and benchmark context.
1D
+1.4%
1M
+6.6%
6M
+4.7%
YTD
+0.9%
1Y
+21.2%
Coverage: 250 bars · Aug 5, 2025 → Aug 4, 2026
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
A is 1.67 pts behind over the shared 1Y window.
A had 20.74 pts deeper max drawdown than SPY.
A beat SPY in 1 of 2 calendar years shown and trailed in 1.
A
+21.16%
Normalized return
SPY
+22.83%
S&P 500
Excess Return
-1.67 pts
Relative to SPY
A Max Drawdown
-29.87%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for A and SPY.
| Year | A | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | +0.91% | +12.67% | -11.77 pts | SPY |
| 2025 | +19.78% | +9.40% | +10.38 pts | A |
EPS Consensus
2.02
Range 2.00 -> 2.03
No analyst count
vs prior: +13.1%Revenue Outlook
$2.2B
Range $2.2B -> $2.2B
No analyst count
vs prior: +6.0%Price Target
--
-- -> --
No analyst count
Recommendations
--
No recommendation feed
No date
Consensus Spread
Lower spread suggests tighter agreement across covering analysts.
Next Earnings
EPS --
Revenue --
No analyst count
EPS Revisions
No recent EPS revision rows
0 revision rows
Trend
Consensus average across visible periods
Trend
Average analyst revenue estimate
Timeline
Sorted by period end date. Includes both cached rows and live fallbacks from the configured analyst feed.
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.